找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Cardiovascular Risk in Type 2 Diabetes Mellitus; Assessment and Contr Nicolae Hancu Book 2003 Springer-Verlag Berlin Heidelberg 2003 cardio

[復(fù)制鏈接]
樓主: 太平間
41#
發(fā)表于 2025-3-28 15:06:59 | 只看該作者
Thom C. Potempa,Mary Fanett Wheelersuggested that Thiazolidinediones have potentially favorable effects on the diabetes associated proath-erogenic metabolic abnormalities including decrease in blood pressure, correction of diabetic dyslipidemia, improvement of fibrinolysis, and decrease in carotid artery intima-media thickness.In thi
42#
發(fā)表于 2025-3-28 19:32:03 | 只看該作者
43#
發(fā)表于 2025-3-29 00:26:12 | 只看該作者
The Heavy Burden of Cardiovascular Disease in Type 2 Diabetes, 2 diabetic patients and nondiabetic individuals. The correction of poor glycemic control reduces microvascular complications but its effect on the prevention of cardiovascular disease is more limited. Drug treatment of established cardiovascular disease in patients with type 2 diabetes should follo
44#
發(fā)表于 2025-3-29 06:01:08 | 只看該作者
Atherogenesis in Diabetes,in other known CVD risk factors. However, diabetic status appears to confer risk such that even after correction of other risk factors, the diabetic remains at high risk for macrovascular disease. The excess risk is so high that being diabetic is considered to place a patient in the same risk catego
45#
發(fā)表于 2025-3-29 10:51:15 | 只看該作者
Clinical Experience with Repaglinide, the First Prandial Glucose Regulator in Type 2 Diabetes,ke place during periods of low blood glucose. Data from comparative studies show that repaglinide reduces the risk of major hypoglycaemia by more than 50%, compared with sulphonylureas. This advantage may be even more marked when the patient is free to adopt a flexible/normal meal pattern. To reduce
46#
發(fā)表于 2025-3-29 13:17:16 | 只看該作者
47#
發(fā)表于 2025-3-29 19:04:25 | 只看該作者
Cardiovascular Risk in Obese Type 2 Diabetes Mellitus Patients,geted and multifactorial interventions. Structured programme as: therapy, education, monitoring, evaluation should be applied. Weight loss is a major therapeutic goal. Lifestyle optimization, through hypocaloric diet and physical activity and specific medication for obesity, are methods to be consid
48#
發(fā)表于 2025-3-29 23:09:26 | 只看該作者
The Hypertriglyceridemic Waist Concept: Implication for Evaluation and Management of Cardiovascular]. Android obesity has also been referred to as upper body obesity, central obesity or abdominal obesity. This condition is obviously more frequently observed in men than in women. Gynoid obesity, also referred to as lower body obesity or peripheral obesity, is the typical body fat distribution patt
49#
發(fā)表于 2025-3-30 00:28:44 | 只看該作者
50#
發(fā)表于 2025-3-30 05:41:51 | 只看該作者
The Prothrombotic Syndrome in Type 2 Diabetes: Assessment and Control,s are therefore relevant only in context with hyperreactive platelets and endothelial lesions or dysfunction. Correction of overweight and the improved metabolic control would however diminish the pathologically increased plasma levels of protrombothic hemostatic variables and in association with an
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-7 06:59
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
乐业县| 四子王旗| 巴彦县| 会东县| 南汇区| 苗栗县| 安庆市| 乌兰浩特市| 勐海县| 清流县| 渑池县| 马边| 金门县| 屯门区| 芜湖县| 贵港市| 克拉玛依市| 哈尔滨市| 文山县| 怀柔区| 康平县| 冷水江市| 和静县| 高尔夫| 天祝| 镇赉县| 宣城市| 黄山市| 宣武区| 武山县| 永寿县| 潼关县| 云安县| 昌邑市| 榆树市| 宜君县| 江门市| 延吉市| 宝兴县| 友谊县| 普兰县|